A Pilot Study to Evaluate the Safety and Tolerability of CeraVe® Lotion Followed by Fixed Dose Clindamycin Phosphate 1.2% / Benzoyl Peroxide 2.5% Gel in the Morning in Combination With CeraVe® Lotion Followed by Tretinoin 0.05% Gel in the Evening for the Treatment of Facial Acne Vulgaris.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Benzoyl peroxide/clindamycin; Tretinoin
- Indications Acne vulgaris
- Focus Adverse reactions
- 12 Oct 2011 New trial record
- 07 Oct 2011 Biomarkers information updated